- Home
- MTEX vs CDIO Comparison
MTEX vs CDIO Comparison
Compare MTEX & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- CDIO
- Stock Information
- Founded
- MTEX 1993
- CDIO 2017
- Country
- MTEX United States
- CDIO United States
- Employees
- MTEX N/A
- CDIO N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MTEX Health Care
- CDIO Health Care
- Exchange
- MTEX Nasdaq
- CDIO Nasdaq
- Market Cap
- MTEX 14.2M
- CDIO 12.4M
- IPO Year
- MTEX 1999
- CDIO N/A
- Fundamental
- Price
- MTEX $7.99
- CDIO $0.27
- Analyst Decision
- MTEX
- CDIO Buy
- Analyst Count
- MTEX 0
- CDIO 1
- Target Price
- MTEX N/A
- CDIO $2.00
- AVG Volume (30 Days)
- MTEX 2.2K
- CDIO 5.4M
- Earning Date
- MTEX 11-12-2024
- CDIO 11-13-2024
- Dividend Yield
- MTEX N/A
- CDIO N/A
- EPS Growth
- MTEX N/A
- CDIO N/A
- EPS
- MTEX N/A
- CDIO N/A
- Revenue
- MTEX $121,552,000.00
- CDIO $39,138.00
- Revenue This Year
- MTEX N/A
- CDIO $2,093.61
- Revenue Next Year
- MTEX N/A
- CDIO $43.05
- P/E Ratio
- MTEX N/A
- CDIO N/A
- Revenue Growth
- MTEX N/A
- CDIO 1363.10
- 52 Week Low
- MTEX $6.75
- CDIO $0.19
- 52 Week High
- MTEX $10.51
- CDIO $3.56
- Technical
- Relative Strength Index (RSI)
- MTEX 52.49
- CDIO 51.62
- Support Level
- MTEX $7.50
- CDIO $0.21
- Resistance Level
- MTEX $8.52
- CDIO $0.52
- Average True Range (ATR)
- MTEX 0.30
- CDIO 0.07
- MACD
- MTEX -0.04
- CDIO 0.01
- Stochastic Oscillator
- MTEX 57.78
- CDIO 31.55
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.